glp-1 agonists in development Understanding receptor and their impact on drug discovery GLP-1 Receptor Agonist Services for
Description
These findings suggest a potential mechanism through which GLP-1 signaling may reduce glycation-related cellular stress
[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Rubino D., Abrahamsson N., Davies M., Hesse D., Greenway F.L., Jensen C., Lingvay I., Mosenzon O., Rosenstock J., Rubio M.A., et al
As mentioned in the case of CagriSema, natural amylin is a pancreatic hormone that induces satiety and Cagrilintide is a long-acting amylin analogue
It is important to note that while topiramate and atogepant have weight loss as a side effect, they are not FDAindicated/approved for weight loss and should not be used solely for weight management
However, concerns about their potential link to cancers, such as thyroid cancer, have surfaced
